Pharma marketing is undergoing a fundamental shift, and agencies must adapt quickly, said Michael Deichmiller, vice president of client engagement and planning at Butler/Till. In a recent interview at Fierce Pharma Week, Deichmiller pointed to measurement and trust as two of the most disruptive forces shaping the field. He noted that marketers are moving beyond impressions and clicks, embracing marketing science and privacy-safe data practices to deliver results that prove real business impact.
Butler/Till’s strategy centers on a media-first approach, which Deichmiller said distinguishes the agency in a crowded market. With nearly 400 employee-owners, the company leverages media expertise and long-term client relationships to drive growth on both sides. Looking ahead, Deichmiller predicted pharma marketing will need to refocus on physicians as the anchor of patient conversations, creating value through stronger connections between healthcare providers and their patients. Watch the full interview for his take on where the industry is headed next.
Butler/Till’s Michael Deichmiller on the evolution from vanity metrics to meaningful outcomes.
The editorial staff had no role in this post's creation.